UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
July 11, 2006

VIRBAC CORPORATION

(Exact Name of Registrant as Specified in Charter)


Delaware (State of Incorporation)		0-24312 (Commission File No.)		43-1648680 (IRS Employer Identification No.)

3200 Meacham Boulevard
Fort Worth, Texas 76137
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (817) 831-5030

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

	o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

	o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

	o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On July 11, 2006, Virbac Corporation (the “Company”) issued a press release announcing the receipt of Virbac S.A.’s revised proposal to acquire all remaining outstanding shares of Virbac Corporation not already owned. Virbac S.A. revised its proposal to acquire the 39.9% outstanding shares of common stock not already owned by Virbac S.A. or its subsidiaries from $4.15 per share in cash to $4.85 per share in cash, representing an aggregate all cash purchase price of approximately $43.978 million. The press release issued by the Company on July 11, 2006 is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.


99.1		Press release of the Company, dated July 11, 2006

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VIRBAC CORPORATION
Date: July 11, 2006	By:	/s/ Jean M. Nelson
		Jean M. Nelson
		Executive Vice-President and Chief Financial Officer

VIRBAC CORP 8-K